Drug Burden Index Score and Functional Decline in Older People

American Journal of Medicine

Volumn 122, Issue 12, 2009, Pages

  Hilmer, Sarah N ^a,b   Mager, Donald E ^a,c   Simonsick, Eleanor M ^a   Ling, Shari M ^a   Windham, B Gwen ^a   Harris, Tamara B ^a   Shorr, Ronald I ^d   Bauer, Douglas C ^e   Abernethy, Darrell R ^a,f  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNITED STATES PHARMACOPEIA   (United States)

Author keywords

Clinical pharmacology; Geriatrics; Physical function

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; SEDATIVE AGENT;

AGED; AGING; ARTICLE; COMORBIDITY; DRUG BURDEN INDEX SCORE; DRUG EXPOSURE; FEMALE; FUNCTIONAL ASSESSMENT; GAIT; GRIP STRENGTH; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; SCORING SYSTEM;

AGED; AREA UNDER CURVE; BODY BURDEN; CHOLINERGIC ANTAGONISTS; DRUG THERAPY; EXERCISE TEST; FEMALE; GAIT; HAND STRENGTH; HUMANS; HYPNOTICS AND SEDATIVES; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; MUSCLE STRENGTH DYNAMOMETER;

EID: 72049093999     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.02.021     Document Type: Article

References (27)

1. Steel K., Gertman P.M., Crescenzi C., and Anderson J. Iatrogenic illness on a general medical service at a university hospital. N Engl J Med. 304 (1981) 638-642
2. Greenblatt D.J., and Allen M.D. Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program. Br J Clin Pharmacol. 5 (1978) 407-413
3. Montamat S.C., and Cusack B. Overcoming problems with polypharmacy and drug misuse in the elderly. Clin Geriatr Med. 8 (1992) 143-158
4. Gray S.L., Penninx B.W., Blough D.K., et al. Benzodiazepine use and physical performance in community-dwelling older women. J Am Geriatr Soc. 51 (2003) 1563-1570
5. Mulsant B.H., Pollock B.G., Kirshner M., et al. Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry 60 (2003) 198-203
6. Landi F., Russo A., Liperoti R., et al. Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther. 81 (2007) 235-241
7. Guralnik J.M., Ferrucci L., Simonsick E.M., et al. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 332 (1995) 556-561
8. Hutchins L.F., Unger J.M., Crowley J.J., et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 341 (1999) 2061-2067
9. Wenger N.K. Enrollment and maintenance of elderly patients in cardiovascular clinical trials. Am J Geriatr Cardiol. 15 (2006) 352-356
10. Hilmer S.N., Mager D.E., Simonsick E.M., et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 167 (2007) 781-787
11. Cao Y.J., Mager D.E., Simonsick E.M., et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther. 83 (2008) 422-429
12. Groll D.L., To T., Bombardier C., and Wright J.G. The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol. 58 (2005) 595-602
13. Teng E.L., and Chui H.C. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 48 (1987) 314-318
14. Weissman M.M., Sholomskas D., Pottenger M., et al. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol. 106 (1977) 203-214
15. Derogatis L.R., Lipman R.S., Rickels K., et al. The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions. Mod Probl Pharmacopsychiatry 7 (1974) 79-110
16. Gray S.L., LaCroix A.Z., Hanlon J.T., et al. Benzodiazepine use and physical disability in community-dwelling older adults. J Am Geriatr Soc. 54 (2006) 224-230
17. Gill S.S., Bronskill S.E., Normand S.L., et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 146 (2007) 775-786
18. Gurwitz J.H., and Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med. 114 (1991) 956-966
19. Campbell A.J., Robertson M.C., Gardner M.M., et al. Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial. J Am Geriatr Soc. 47 (1999) 850-853
20. Dorph-Petersen K.A., Pierri J.N., Perel J.M., et al. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 30 (2005) 1649-1661
21. Guralnik J.M., Ferrucci L., Pieper C.F., et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci. 55 (2000) M221-M231
22. Fried L.P., Tangen C.M., Walston J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 56 (2001) M146-M156
23. Perera S., Mody S.H., Woodman R.C., and Studenski S.A. Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc. 54 (2006) 743-749
24. Rantanen T., Guralnik J.M., Foley D., et al. Midlife hand grip strength as a predictor of old age disability. JAMA 281 (1999) 558-560
25. Giampaoli S., Ferrucci L., Cecchi F., et al. Hand-grip strength predicts incident disability in non-disabled older men. Age Ageing 28 (1999) 283-288
26. Laukkanen P., Heikkinen E., and Kauppinen M. Muscle strength and mobility as predictors of survival in 75-84-year-old people. Age Ageing 24 (1995) 468-473
27. Newman A.B., Kupelian V., Visser M., et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci. 61 (2006) 72-77